<DOC>
	<DOCNO>NCT01348009</DOCNO>
	<brief_summary>Cisplatin , intravenously administer platinum agent , combination intravenously administer taxane capecitabine show improve time disease progression overall survival previously untreated patient gastric cancer . This study perform evaluate orally administer taxane ( tesetaxel ) combination cisplatin capecitabine previously untreated patient gastric cancer .</brief_summary>
	<brief_title>Tesetaxel Plus Capecitabine Cisplatin Advanced Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Primary At least 20 year age Histologically cytologically confirm gastric carcinoma , include gastric gastroesophagealjunction adenocarcinoma . Measurable disease ( revised RECIST ) base compute tomography , nonmeasurable disease Previously untreated , unresectable advanced ( M0 ) unresectable metastatic ( M1 ) disease except prior adjuvant ( neoadjuvant ) chemotherapy . ECOG performance status 0 1 At least 4 week recovery effect prior major surgery Adequate bone marrow , hepatic , renal function Primary Operable gastric gastroesophagealjunction cancer Known brain metastasis Second cancer Previous adjuvant neoadjuvant chemotherapy capecitabine cisplatin combination . ( Previous adjuvant neoadjuvant monotherapy capecitabine S1 therapy S1 cisplatin combination 5FU cisplatin combination allow . ) Uncontrolled diarrhea Nausea vomit least 3 consecutive day within 14 day prior registration despite administration standard antiemetic therapy Symptomatic peripheral neuropathy â‰¥ Grade 2 Malabsorption syndrome disease significantly affect gastrointestinal function Other uncontrolled systemic illness</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Gastric cancer</keyword>
	<keyword>First-line therapy</keyword>
	<keyword>Tesetaxel</keyword>
	<keyword>Taxane</keyword>
	<keyword>Capecitabine</keyword>
	<keyword>Oral fluoropyrimidine</keyword>
	<keyword>Cisplatin</keyword>
	<keyword>Platinum</keyword>
</DOC>